Accelerate Diagnostics Announces Research Collaboration With CDC Laboratory for Early Detection of Antibiotic-Resistant Biothreat Agents
GlobeNewswire - Mon Nov 03, 12:50PM CST
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms, today announced that it has entered into a research collaboration with the Rapid Antimicrobial Susceptibility Testing Laboratory at the U.S. Centers for Disease Control and Prevention (CDC) to develop tests for the rapid analysis of antibiotic-resistant biothreat agents based on Accelerate's high-speed identification and antibiotic susceptibility testing platform.
AXDX: 18.47 (+0.03)
Nasdaq stocks posting largest percentage decreases
AP - Wed Oct 15, 5:08PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
IMDZ: 34.96 (+0.78), CENT: 8.66 (+0.06), AXDX: 18.47 (+0.03), KTCC: 7.99 (unch), CENTA: 9.30 (+0.06), EXAC: 22.68 (+0.24), LAKE: 8.94 (+0.07), MTEX: 28.96 (unch), IKNX: 15.00 (-0.19)
Accelerate Diagnostics: Mistakenly Rewarded And Destined To Crash?
The Street Sweeper - Seeking Alpha - Tue Oct 14, 10:42AM CDT
Accelerate Diagnostics (NASDAQ: AXDX ) might need to credit a "false positive" for making its stock price look so much healthier these days. Mistaken by some as a promising Ebola play , AXDX has skyrocketed in value over the course of the...
AXDX: 18.47 (+0.03)
Trade-Ideas: Accelerate Diagnostics (AXDX) Is Today's Weak On High Relative Volume Stock
at The Street - Mon Oct 06, 9:02AM CDT
Trade-Ideas LLC identified Accelerate Diagnostics (AXDX) as a weak on high relative volume candidate
AXDX: 18.47 (+0.03)
3 Hot Stocks to Trade (or Not)
at The Street - Fri Oct 03, 2:22PM CDT
Here's how to trade some of the most-active stocks on the market right now.
AXDX: 18.47 (+0.03), PANW: 125.99 (+0.77), MBLY: 44.00 (+0.05)
Accelerate Diagnostics Supports Drug Stewardship and Early Detection in the President's Initiative to Combat Antibiotic-Resistant Bacteria
GlobeNewswire - Thu Sep 25, 1:35PM CDT
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms, today commended the Obama Administration's actions to combat antibiotic-resistant bacteria, and underscored two areas of critical importance.
AXDX: 18.47 (+0.03)
Matthew Strobeck of Accelerate Diagnostics, Inc. (AXDX)-Nasdaq bought Shares of AXDX
M2 - Thu Aug 07, 11:11AM CDT
Reported by InsiderCow.com at 2014-08-06 12:48:50 ET
AXDX: 18.47 (+0.03)
5 Stocks Insiders Love Right Now
at The Street - Wed Jul 23, 12:03PM CDT
Insiders at these companies have been scooping up shares of their own stock lately.
AA: 15.77 (+0.04), AXDX: 18.47 (+0.03), BCRH: 17.53 (-0.12), CFX: 52.40 (-0.35), SYRG: 12.97 (-0.04)
Multiple Insiders of Accelerate Diagnostics, Inc. (AXDX)-NasdaqCM bought Shares of AXDX
M2 - Mon Jul 21, 8:37AM CDT
Reported by InsiderCow.com at 2014-07-18 10:04:13 ET
AXDX: 18.47 (+0.03)
The 5 Best Healthcare Stocks so Far in 2014
Todd Campbell, The Motley Fool - Motley Fool - Sun Jul 06, 8:30AM CDT
Healthcare stocks put up impressive returns last year and are trumping the S&P 500 yet again this year. The S&P health care select index ETF (XLV) is up more than 10% this year and the iShares Nasdaq biotechnology ETF (IBB) has gained...
AXDX: 18.47 (+0.03), ACHN: 13.06 (+1.22), ITMN: 73.89 (-0.02), HZNP: 12.38 (+0.13), ICPT: 151.49 (+5.85)
3 Stocks Crushed by the Market This Week
Keith Speights, The Motley Fool - Motley Fool - Sat Jul 05, 2:00PM CDT
Shareholders of these three health-care stocks could be wishing for a do-over for the start of July. One of the week's big losers appears to have been hurt by being dropped from a well-known index. Another reported late-stage clinical study results...
GEVA: 89.72 (-0.02), AXDX: 18.47 (+0.03), STAA: 9.11 (-0.08)